Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group

RALEIGH, N.C., April 28 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotech industry, today announced that Doug Linton has joined its Executive Advisory Group. The group is made up of industry professionals brought together by Campbell Alliance CEO John Campbell to bring special expertise to highly complex engagements. Mr. Linton will focus on distribution-related issues, working closely with Campbell Alliance's Trade and Distribution Practice.

Mr. Linton started with Cardinal Health, a global manufacturer and distributor of medical and surgical supplies and technologies, in 1981, and he has worked in the pharmaceutical distribution field for more than 20 years. At Cardinal, he played a key role developing the sophisticated investment buying program and central purchasing system that powered the firm's consolidation strategy, which transformed it from a small regional player in the early 1980s to a highly profitable national drug wholesaler by the mid- 1990s. Mr. Linton also developed and was president of several very profitable new business units for Cardinal, including National PharmPak Services, a re- packaging company, and National Specialty Services, which focused on distribution of plasma and oncology products. Mr. Linton reported to the founder and CEO of Cardinal Health during a majority of his tenure and was a member of senior management.

After leaving Cardinal in 1995, Mr. Linton worked as a senior executive with two regional drug wholesalers to develop purchasing capabilities similar to those he established at Cardinal. He then returned to Cardinal as a consultant to develop an analytical fee-for-service program for smaller manufacturers, and he directed its implementation with more than 60 manufacturers in less than twelve months. Today that program is used with close to 200 manufacturers.

After leaving Cardinal two years ago, Mr. Linton consulted to over 20 pharmaceutical companies. In addition, he served as a member of the board of directors of Bradley Pharmaceuticals from November 2006 until February 2008, when it was acquired by Nycomed.

"Doug adds a wealth of expertise to the team working on complex trade and distribution-related issues here at the firm. Doug's leadership and the practical experience he has amassed over the past two decades will undoubtedly help guide our efforts to serve the pharmaceutical and biotech companies that depend on us for this expertise," stated Tony Lanzone, vice president and head of the Trade and Distribution Practice at Campbell Alliance.

Mr. Linton graduated with a degree in Economics with honors from the College of Wooster (Ohio) and an MBA from Carnegie Mellon University.

About the Trade and Distribution Practice at Campbell Alliance

The Trade and Distribution Practice at Campbell Alliance focuses on helping clients make better strategic decisions surrounding distribution- related business challenges at the product, portfolio, and corporate levels. Services include:

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry. The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, Sales, and Trade and Distribution. From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Atlanta, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

SOURCE Campbell Alliance

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.